Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Return on Equity (2020 - 2023)

Historic Return on Equity for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to 0.32%.

  • Terns Pharmaceuticals' Return on Equity rose 500.0% to 0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.32%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.28% for FY2022, which is 20700.0% up from last year.
  • Terns Pharmaceuticals' Return on Equity amounted to 0.32% in Q3 2023, which was up 500.0% from 0.26% recorded in Q2 2023.
  • Terns Pharmaceuticals' Return on Equity's 5-year high stood at 0.35% during Q4 2020, with a 5-year trough of 1.26% in Q1 2021.
  • Moreover, its 4-year median value for Return on Equity was 0.28% (2021), whereas its average is 0.32%.
  • Its Return on Equity has fluctuated over the past 5 years, first tumbled by -6500bps in 2021, then soared by 9400bps in 2022.
  • Quarter analysis of 4 years shows Terns Pharmaceuticals' Return on Equity stood at 0.35% in 2020, then crashed by -186bps to 0.3% in 2021, then increased by 13bps to 0.26% in 2022, then dropped by -22bps to 0.32% in 2023.
  • Its Return on Equity was 0.32% in Q3 2023, compared to 0.26% in Q2 2023 and 0.24% in Q1 2023.